Table 2 Epidemic profiles of hepatitis B and C infection in the countries covered by the survey

HBV epidemiology

Country number (%) and name

High seroprevalence (>5%) in general population

12 (54.5%)

Gambia, Thailand, Chad, Mongolia, Côte d’Ivoire, Vietnam, Niger, Uganda, Hong Kong SAR/China, Democratic Republic of the Congo, Tanzania, Kenya

Intermediate seroprevalence (3-5%) in general population

3 (13.6%)

Fiji, Philippines, Myanmar

Low seroprevalence (<3%) in general population

3 (13.6%)

Ukraine, India, Georgia

HCV epidemiology based on anti-HCV antibody

Country number (%) and name

High seroprevalence (>3%) in general population and concentrated epidemic among PWID

3 (13.6%)

Georgia, Mongolia, Ukraine

Intermediate/low seroprevalence (1-3%) in general population but concentrated epidemic among PWID

5 (22.7%)

India, Philippines, Thailand, Myanmar, Vietnam

Low seroprevalence (<1%) in general population

9 (40.9%)

Chad, Côte d’Ivoire, Democratic Republic of the Congo, Gambia, Hong Kong SAR/China, Kenya, Niger, Tanzania, Uganda